Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?
Hepatic Oncology · 2016
DOI: 10.2217/hep-2015-0001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hepatic Oncology, 2016. Verfasst von Thierry de Baere und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Image Guided Therapy, Gustave Roussy-Cancer Campus, Villejuif, France. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Conventional transarterial chemoembolization (c-TACE) was validated in 2002 for intermediate stage hepatocellular carcinoma (HCC). Recent improvements in overall survival after c-TACE in HCC is linked to both better patient selection, and improvement in treatment technologies: catheter, image guidance and new drug delivery platforms. Drug eluting beads (DEBs) demonstrated a benefit over c-TACE in pharmacokinetic studies; however, two randomized studies comparing c-TACE and DEB-TACE demonstrated no benefit of DEB-TACE in response rate or overall survival. Delivery platforms loaded with yttrium-90 deliver selective internal radiation therapy, which opens a new field of therapy for HCC. Future improvement in intra-arterial therapies will include resorbable loadable embolic material, new emulsion used for c-TACE and platforms releasing multikinase inhibitors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Image Guided Therapy, Gustave Roussy-Cancer Campus, Villejuif, France.
- Université Paris-Sud XI, UFR Médecine Le Kremlin-Bicêtre, Le Kremlin Bicêtre, France.
Zitieren
APA
de Baere, T., Tselikas, L., Deschamps, F., Boige, V., Ducreux, M., & Hollebecque, A. (2016). Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?. Hepatic Oncology. https://doi.org/10.2217/hep-2015-0001
Vancouver
de Baere T, Tselikas L, Deschamps F, Boige V, Ducreux M, Hollebecque A. Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?. Hepatic Oncology. 2016. doi:10.2217/hep-2015-0001
BibTeX
@article{deBaere2016,
author = {de Baere, Thierry and Tselikas, Lambros and Deschamps, Frederic and Boige, Valerie and Ducreux, Michel and Hollebecque, Antoine},
title = {Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?},
journal = {Hepatic Oncology},
year = {2016},
doi = {10.2217/hep-2015-0001}
}
EUVIMED